Indianapolis, IN, United States of America

Mark Steven Kerr

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 7.7

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mark Steven Kerr

Introduction

Mark Steven Kerr, an accomplished inventor based in Indianapolis, IN, has made significant strides in the field of pharmaceutical innovations. With two powerful patents to his name, Kerr's work continues to impact the development of medications in the healthcare industry.

Latest Patents

Kerr's latest patents focus on processes and intermediates for the large-scale preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate and its acetate form. These embodiments outline innovative methods for producing this compound in substantial quantities, including formulations for tablet products that deliver variable dosages of 25 mg, 50 mg, 100 mg, or 200 mg free base equivalent of the active ingredient. The formulations created by these processes are designed to ensure effective delivery and reliability for patients needing this treatment.

Career Highlights

Kerr works at Eli Lilly and Company, a leading global healthcare firm where he plays a pivotal role in advancing medical technologies and pharmaceutical innovations. His substantial experience in developing efficient processes for large-scale pharmaceutical production has positioned him as a valuable asset to his team and the broader pharmaceutical community.

Collaborations

Throughout his career, Kerr has collaborated with talented professionals including Aktham Aburub and David Andrew Coates. These collaborations have allowed for a synergy of ideas and expertise that drive innovation and lead to groundbreaking advancements in their field.

Conclusion

Mark Steven Kerr's dedication to innovation showcases the crucial role inventors play in the pharmaceutical industry. His contributions through significant patents highlight the importance of developing effective medications and processes that improve patient care and outcomes. As he continues to work with Eli Lilly and Company, there is no doubt that Kerr will inspire future innovations in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…